Français
ItalianoBond BioMarin Pharmaceutical 5.5% ( USU09036AA91 ) in USD
| Issuer | BioMarin Pharmaceutical | ||||||||
| Market price |  100.73 % ⇌ |
||||||||
| Country |  United States
|
||||||||
| ISIN code |
 USU09036AA91 ( in USD )
|
||||||||
| Interest rate | 5.5% per year ( payment 2 times a year) | ||||||||
| Maturity | 15/02/2034 | ||||||||
|
Prospectus brochure in PDF format |
|||||||||
| Minimal amount | / | ||||||||
| Total amount | / | ||||||||
| Cusip | U09036AA9 | ||||||||
| Standard & Poor's ( S&P ) rating | BB ( Non-investment grade speculative ) | ||||||||
| Next Coupon | 15/02/2027 ( In 172 days ) | ||||||||
| Detailed description |
American biotechnology company specializing in therapies for rare genetic diseases. The Bond issued by BioMarin Pharmaceutical ( United States ) , in USD, with the ISIN code USU09036AA91, pays a coupon of 5.5% per year. The coupons are paid 2 times per year and the Bond maturity is 15/02/2034 The Bond issued by BioMarin Pharmaceutical ( United States ) , in USD, with the ISIN code USU09036AA91, was rated BB ( Non-investment grade speculative ) by Standard & Poor's ( S&P ) credit rating agency. |
||||||||
| |||||||||